253 related articles for article (PubMed ID: 8494373)
1. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
Tsuchiya M; Imamura L; Park JB; Kobashi K
Biol Pharm Bull; 1995 Aug; 18(8):1053-6. PubMed ID: 8535394
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.
Nagata K; Takagi E; Satoh H; Okamura H; Tamura T
Antimicrob Agents Chemother; 1995 Oct; 39(10):2187-92. PubMed ID: 8619564
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
Nakao M; Malfertheiner P
Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
[TBL] [Abstract][Full Text] [Related]
6. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
Midolo PD; Turnidge JD; Lambert JR; Bell JM
Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
[TBL] [Abstract][Full Text] [Related]
7. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
Dickey W; Kenny BD; McConnell JB
Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
[TBL] [Abstract][Full Text] [Related]
8. The chemotherapeutic effects of H+/K+ inhibitors on Helicobacter pylori infection.
Logan RP
Pharmacol Ther; 1996; 69(1):79-83. PubMed ID: 8857304
[TBL] [Abstract][Full Text] [Related]
9. Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.
Saniee P; Shahreza S; Siavoshi F
Helicobacter; 2016 Apr; 21(2):143-52. PubMed ID: 26222264
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of YJA20379, a new proton pump inhibitor on Helicobacter pylori growth and urease.
Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
Arch Pharm Res; 1998 Feb; 21(1):6-11. PubMed ID: 9875507
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
Nakao M; Tada M; Tsuchimori K; Uekata M
Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
[TBL] [Abstract][Full Text] [Related]
12. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
Iwahi T; Satoh H; Nakao M; Iwasaki T; Yamazaki T; Kubo K; Tamura T; Imada A
Antimicrob Agents Chemother; 1991 Mar; 35(3):490-6. PubMed ID: 2039199
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
Nakao M
J Clin Gastroenterol; 1995; 20 Suppl 1():S32-7. PubMed ID: 7673612
[TBL] [Abstract][Full Text] [Related]
14. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.
Nagata K; Sone N; Tamura T
Antimicrob Agents Chemother; 2001 May; 45(5):1522-7. PubMed ID: 11302821
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial activity of cefdinir and omeprazole against Helicobacter pylori and their inhibition on H. pylori-producing urease].
Yokoya Y; Ikeda F; Mine Y
Kansenshogaku Zasshi; 1993 Sep; 67(9):808-15. PubMed ID: 8409593
[TBL] [Abstract][Full Text] [Related]
17. Biological evaluation and molecular docking of baicalin and scutellarin as Helicobacter pylori urease inhibitors.
Yu XD; Zheng RB; Xie JH; Su JY; Huang XQ; Wang YH; Zheng YF; Mo ZZ; Wu XL; Wu DW; Liang YE; Zeng HF; Su ZR; Huang P
J Ethnopharmacol; 2015 Mar; 162():69-78. PubMed ID: 25557028
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth.
Nakajima N; Kuwayama H; Iwasaki A; Arakawa Y
J Clin Gastroenterol; 1995; 20 Suppl 2():S90-2. PubMed ID: 7594352
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid.
Goldie J; Veldhuyzen van Zanten SJ; Jalali S; Richardson H; Hunt RH
J Clin Pathol; 1991 Aug; 44(8):695-7. PubMed ID: 1890207
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of lansoprazole against Helicobacter pylori.
Figura N; Crabtree JE; Dattilo M
J Antimicrob Chemother; 1997 May; 39(5):585-90. PubMed ID: 9184356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
